Cargando…
Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune Responses
The influence of DNA vaccine formulations on immune responses in combination with adjuvants was investigated with the aim to increase cell-mediated immunity against plasmid DNA (pDNA) encoding Mycobacterium tuberculosis antigen 85A. Different ratios of pDNA with cationic trimethyl chitosan (TMC) nan...
Autores principales: | Poecheim, Johanna, Barnier-Quer, Christophe, Collin, Nicolas, Borchard, Gerrit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041026/ https://www.ncbi.nlm.nih.gov/pubmed/27626449 http://dx.doi.org/10.3390/vaccines4030032 |
Ejemplares similares
-
Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR-2 Ligands Leads to Synergistic Enhancement of Proinflammatory Cytokine Release
por: Poecheim, Johanna, et al.
Publicado: (2015) -
A Comparison of Intramuscular and Subcutaneous Administration of LigA Subunit Vaccine Adjuvanted with Neutral Liposomal Formulation Containing Monophosphoryl Lipid A and QS21
por: Techawiwattanaboon, Teerasit, et al.
Publicado: (2020) -
Better Pandemic Influenza Preparedness through Adjuvant Technology Transfer: Challenges and Lessons Learned
por: Lemoine, Céline H., et al.
Publicado: (2021) -
Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation
por: Younis, Sumera Y., et al.
Publicado: (2018) -
Pulmonary Delivery of Plasmid DNA for Disease Prevention and Therapy
por: Heuking, Simon, et al.
Publicado: (2011)